European Commission logo
English English
CORDIS - EU research results
CORDIS

Development of a simple and rapid assay for early diphtheria diagnosis.

Project description

An innovative diagnostic test for diphtheria

Corynebacterium diphtheriae, the pathogenic agent of diphtheria, poses a serious health risk to non-vaccinated individuals or those with a weak immune system. Considering the increase in diphtheria cases among Asian and African migrants, scientists of the EU-funded DIFTERIA project have raised the issue of a reliable diagnostic method to prepare for a possible epidemic. The proposed method will detect the diphtheria toxin using an immunochromatographic strip (ICS) in just six hours. Implementation of this novel test will improve the accuracy of diphtheria diagnosis and enable the timely initiation of treatment, thereby preventing the spread of the pathogen in the community.

Objective

During 1990s, there was an epidemic of diphtheria in Russia and other countries of the former USSR affecting about 200, 000 people with 5000 deaths. Although diphtheria incidence in Russia has declined substantially, recent reports from several EU countries indicate circulation of toxigenic C. diphtheriae among migrants from Asia and Africa as well as children’s deaths among indigenous population. Toxigenic C. diphtheriae poses a serious risk for unvaccinated persons and persons with low level of immunological protection, the number of which in recent times in Europe has increased. The International system of quality control revealed poor state of laboratory diagnosis of diphtheria in EU countries, which means we are not prepared for the possible outbreaks. This is mostly due to the absence of simple, standard and reliable diagnostic methods.

The leading element in the diphtheria laboratory diagnostic approach is a detection of the bacterial toxin. In this regard, it is proposed to develop non-apparatus immunochromatographic strip (ICS) test for diphtheria toxin (DT) indication. In addition a liquid selective medium for the clinical sample cultivation will be designed. A combination of the ICS test and the medium will represent a novel assay for early diphtheria diagnosis. The reagent kit will be commercially produced. The availability of simple, reliable and affordable ICS assay for DT detection will increase the accuracy of diphtheria diagnosis in EU and other countries and reduce the duration of its execution up to 6 hours (instead of 5-7 days as recommended by the WHO manual). The efficient early diphtheria diagnosis will enable timely initiation of anti-diphtheritic treatment that will save lives, prevent the development of complications (heart failure, paralysis), as well as stop the spread of the disease through initiation of preventive measures (vaccination and antibiotic prophylaxis) in case of disease outbreaks.

Coordinator

SENOVA GESELLSCHAFT FUR BIOWISSENSCHAFT UND TECHNICK MBH
Net EU contribution
€ 174 806,40
Address
INDUSTRIESTR. 8
99427 Weimar
Germany

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Thüringen Thüringen Weimar, Kreisfreie Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 174 806,40